198例胃癌手术标本Her-2蛋白表达与临床病理的相关性和靶向治疗(13)

：通过组织芯片(t i S S U e m i C r o a rr Y,T MA)和免疫组织化学(inununohistochemistry,IHC)技术检测人类表皮生长因子受体2(tluman epidermal growth factor receptor2,Her-2)在胃癌(gastric carcinoma,GC)中的表达,研究胃癌中Her-2表达的临床意义,为胃癌靶向治疗奠定理论基础。方法：构建包含198例胃癌组织和89例正常胃黏膜的组织芯片,分析Her-2表达与临床病理参数之间的相关性及其对预后的影响。

198例胃癌手术标本Her-2蛋白表达与临床病理的相关性和靶向治疗

作者：作者单位：

奚文崎， 张本炎， 金晓龙， 杨卫平， 燕敏， 王建承， XI Wen-qi， ZHANG Ben-yan，JIN Xiao-long， YANG Wei-ping， YAN Min， WANG Jian-cheng

奚文崎,XI Wen-qi(上海交通大学医学院附属瑞金医院肿瘤科,上海,200025)， 张本炎,金晓龙,ZHANG Ben-yan,JIN Xiao-long(上海交通大学医学院附属瑞金医院病理科,上海,200025)， 杨卫平,燕敏,王建承,YANG Wei-ping,YAN Min,WANG Jian-cheng(上海交通大学医学院附属瑞金医院普外科,上海,200025)中国癌症杂志CHINA ONCOLOGY2010,20(12)1次

刊名：英文刊名：年，卷(期)：被引用次数：

参考文献(52条)

1.Muhammad Wasif Saif.Nianwen Shi.Susan Zelt Capecitabine treatment patterns in patients withgastroesophageal cancer in the United States 2009(35)

2.Muhammad WS;Nianwen S;Susan Z Capecitabine treatment patterns in patients with gastroesophagealcancer in the United States[期刊论文]-World Journal of Gastroenterology 2009(35)3.Kelley JR.Duggan JM Gastric cancer epidemiology and risk factors 2003

4.Kelley JR;Duggan JM Gastric cancer epidemiology and risk factors[外文期刊] 20035.许晓勇.胡乃中.石海.曹富流.许建明 222例早期胃癌的临床病理及预后分析 2009(4)

6.许晓勇;胡乃中;石海 222例早期胃癌的临床病理及预后分析[期刊论文]-中华消化内镜杂忐 2009(04)

7.Van Cutsem E.Kang Y.Chung H Efficacy results from the ToGA trial:A phrase Ⅲ study of trastuzumabadded to standard chemotherapy(CT) in first-line human epidermal growth factor receptor 2(Her-2)-positive advanced gastric cancer(GC) 2009(18S)

8.Van Cutsem E;Kang Y;Chung H Efficacy results from the ToGA trial:A phrase Ⅲ study of trastuzumabadded to standard chemotherapy(CT) in first-line human epidermal growth factor receptor 2(Her-2)-positive advanced gastric cancer(GC) 2009(18S)

9.Akiyama T;Sudo C;Ogawara H The product of the human c-erbB-2 gene:A 185-kilo-Dalton glycoproteinwith tyrosine kinase activity[外文期刊] 1986

搜索“diyifanwen.net”或“第一范文网”即可找到本站免费阅读全部范文。收藏本站方便下次阅读，第一范文网，提供最新工程科技198例胃癌手术标本Her-2蛋白表达与临床病理的相关性和靶向治疗(13)全文阅读和word下载服务。